Clinical features and diagnosis of epidermolysis bullosa acquisita

References

• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911–920.
   PubMed Web of Science ®Google Scholar
• Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol. 2016;11:175–197.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–332.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Groves R. Immunobullous diseases. In: Griffith C, Barker J, Chalmers R, Bleiker T, Creamer D, editors. Rook’s textbook of dermatology, part 3, chapter 50. 9th ed. Chichester: Wiley-Blackwell; 2016. Vol. 50, p. 1–56.
   Google Scholar
• Ludwig RJ. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol. 2013;812029:2013.
   Google Scholar
• Kasperkiewicz M, Sadik CD, Bieber K, et al. Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options. J Invest Dermatol. 2016;136(1):24–33.
   PubMed Web of Science ®Google Scholar
• Keene DR, Sakai LY, Lunstrum GP, et al. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol. 1987;104(3):611–621.
   PubMed Web of Science ®Google Scholar
• Lunstrum GP, Sakai LY, Keene DR, et al. Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils. J Biol Chem. 1986;261(19):9042–9048.
   PubMed Web of Science ®Google Scholar
• Sakai LY, Keene DR, Morris NP, et al. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986;103(4):1577–1586.
   PubMed Web of Science ®Google Scholar
• Roenigk HH Jr, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):1–10.
   PubMedGoogle Scholar
• Gammon WR, Briggaman RA, Woodley DT, et al. Epidermolysis bullosa acquisita–a pemphigoid-like disease. J Am Acad Dermatol. 1984;11(5 Pt 1):820–832.
   PubMed Web of Science ®Google Scholar
• Kurzhals G, Stolz W, Meurer M, et al. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol. 1991;127(3):391–395.
   PubMedGoogle Scholar
• Zambruno G, Manca V, Kanitakis J, et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol. 1994;31(5 Pt 2):884–888.
   PubMed Web of Science ®Google Scholar
• Dahl MG. Epidermolysis bullosa acquisita–a sign of cicatricial pemphigoid? Br J Dermatol. 1979;101(4):475–484.
   PubMed Web of Science ®Google Scholar
• Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis. 1895;13:10–18.
   Google Scholar
• Woodley DT, Briggaman RA, O’Keefe EJ, et al. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984;310(16):1007–1013.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Burgeson RE, Lunstrum G, et al. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988;81(3):683–687.
   PubMed Web of Science ®Google Scholar
• Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol. 1999;112(4):411–418.
   PubMed Web of Science ®Google Scholar
• Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995;131(1):48–52.
   PubMed Web of Science ®Google Scholar
• Bertram F, Brocker EB, Zillikens D, et al. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7(5):434–440.
   PubMed Web of Science ®Google Scholar
• Zillikens D, Wever S, Roth A, et al. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol. 1995;131(8):957–958.
   PubMedGoogle Scholar
• Nanda A, Dvorak R, Al-Saeed K, et al. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol. 2004;43(12):876–881.
   PubMed Web of Science ®Google Scholar
• Wong SN, Chua SH. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol. 2002;147(3):476–480.
   PubMed Web of Science ®Google Scholar
• Hübner F, Recke A, Zillikens D, et al. Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol. 2016. doi:10.1016/j.jid.2016.07.013.
   PubMed Web of Science ®Google Scholar
• Zumelzu C, Le Roux-Villet C, Loiseau P, et al. Black patients of African descent and HLA-DRB115:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol. 2011;131(12):2386–2393.
   PubMed Web of Science ®Google Scholar
• Buijsrogge JJ, Diercks GF, Pas HH, et al. The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol. 2011;165(1):92–98.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YH, Kim SC. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol. 2011;91(3):307–312.
   PubMed Web of Science ®Google Scholar
• Gammon WR. Epidermolysis bullosa acquisita. Semin Dermatol. 1988;7(3):218–224.
   PubMedGoogle Scholar
• Arpey CJ, Elewski BE, Moritz DK, et al. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol. 1991;24((5 Pt 1):706–714.
   PubMed Web of Science ®Google Scholar
• Guerra L, Pacifico V, Calabresi V, et al. Childhood epidermolysis bullosa acquisita during squaric acid dibutylester (SADBE) immunotherapy for alopecia areata. Br J Dermatol. 2016. doi:10.1111/bjd.14764
   PubMedGoogle Scholar
• Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin. 1993;11(3):535–547.
   PubMed Web of Science ®Google Scholar
• Gammon WR, Heise ER, Burke WA, et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol. 1988;91(3):228–232.
   PubMed Web of Science ®Google Scholar
• Lee CW, Kim SC, Han H. Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. Dermatology. 1996;193(4):328–329.
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Recke A, Bieber K, et al. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J Invest Dermatol. 2011;131(1):167–176.
   PubMed Web of Science ®Google Scholar
• Chen M, O’Toole EA, Sanghavi J, et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn’s disease have autoantibodies to type VII collagen. J Invest Dermatol. 2002;118(6):1059–1064.
   PubMed Web of Science ®Google Scholar
• Hundorfean G, Neurath MF, Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med. 2010;14(10):2393–2403.
   PubMed Web of Science ®Google Scholar
• Ishii N, Hamada T, Dainichi T, et al. Epidermolysis bullosa acquisita: what’s new? J Dermatol. 2010;37(3):220–230.
   PubMed Web of Science ®Google Scholar
• Chen M, Kim GH, Prakash L, et al. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45(1):91–101.
   PubMed Web of Science ®Google Scholar
• Schulze F, Neumann K, Recke A, et al. Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol. 2015;135(5):1445–1447.
   PubMed Web of Science ®Google Scholar
• Aractingi S, Bachmeyer C, Prost C, et al. Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders. Medicine (Baltimore). 1999;78(4):228–235.
   PubMed Web of Science ®Google Scholar
• Delbaldo C, Chen M, Friedli A, et al. Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen. J Am Acad Dermatol. 2002;46(5 Suppl):S161–164.
   PubMed Web of Science ®Google Scholar
• Jappe U, Zillikens D, Bonnekoh B, et al. Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. Br J Dermatol. 2000;142(3):517–520.
   PubMed Web of Science ®Google Scholar
• Baican A, Chiriac G, Baican C, et al. Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita. J Dermatol. 2010;37(3):280–282.
   PubMed Web of Science ®Google Scholar
• Wakelin SH, Allen J, Zhou S, et al. Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol. 1998;138(2):310–314.
   PubMed Web of Science ®Google Scholar
• Burgeson RE. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol. 1993;101(3):252–255.
   PubMed Web of Science ®Google Scholar
• Chen M, Marinkovich MP, Jones JC, et al. NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol. 1999;112(2):177–183.
   PubMed Web of Science ®Google Scholar
• Chen M, Marinkovich MP, Veis A, et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem. 1997;272(23):14516–14522.
   PubMed Web of Science ®Google Scholar
• Rousselle P, Keene DR, Ruggiero F, et al. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol. 1997;138(3):719–728.
   PubMed Web of Science ®Google Scholar
• Brittingham R, Uitto J, Fertala A. High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun. 2006;343(3):692–699.
   PubMed Web of Science ®Google Scholar
• Villone D, Fritsch A, Koch M, et al. Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J Biol Chem. 2008;283(36):24506–24513.
   PubMed Web of Science ®Google Scholar
• Woodley DT, O’Keefe EJ, McDonald JA, et al. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. J Clin Invest. 1987;79(6):1826–1830.
   PubMed Web of Science ®Google Scholar
• Jones DA, Hunt SW III, Prisayanh PS, et al. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol. 1995;104(2):231–235.
   PubMed Web of Science ®Google Scholar
• Lapiere JC, Woodley DT, Parente MG, et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest. 1993;92(4):1831–1839.
   PubMed Web of Science ®Google Scholar
• Ishii N, Yoshida M, Ishida-Yamamoto A, et al. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol. 2009;160(5):1090–1093.
   PubMed Web of Science ®Google Scholar
• Saleh MA, Ishii K, Kim YJ, et al. Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci. 2011;62(3):169–175.
   PubMed Web of Science ®Google Scholar
• Callot-Mellot C, Bodemer C, Caux F, et al. Epidermolysis bullosa acquisita in childhood. Arch Dermatol. 1997;133(9):1122–1126.
   PubMedGoogle Scholar
• Tanaka H, Ishida-Yamamoto A, Hashimoto T, et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest. 1997;77(6):623–632.
   PubMed Web of Science ®Google Scholar
• Park SB, Cho KH, Youn JL, et al. Epidermolysis bullosa acquisita in childhood–a case mimicking chronic bullous dermatosis of childhood. Clin Exp Dermatol. 1997;22(5):220–222.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Hopfner B, Chen M, et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol. 2002;147(3):592–597.
   PubMed Web of Science ®Google Scholar
• Gupta R, Woodley DT, Chen M. Epidermolysis bullosa acquisita. Clin Dermatol. 2012;30(1):60–69.
   PubMed Web of Science ®Google Scholar
• Vorobyev A, Ujiie H, Recke A, et al. Autoantibodies to multiple epitopes on the non-collagenous-1 domain of Type VII collagen induce blisters. J Invest Dermatol. 2015;135(6):1565–1573.
   PubMed Web of Science ®Google Scholar
• Chen M, Keene DR, Costa FK, et al. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J Biol Chem. 2001;276(24):21649–21655.
   PubMed Web of Science ®Google Scholar
• Bernard P, Prost C, Aucouturier P, et al. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol. 1991;97(2):259–263.
   PubMed Web of Science ®Google Scholar
• Oostingh GJ, Sitaru C, Zillikens D, et al. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37(3):182–184.
   PubMed Web of Science ®Google Scholar
• Komorowski L, Muller R, Vorobyev A, et al. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol. 2012;68(3):e89–95.
   PubMed Web of Science ®Google Scholar
• Gandhi K, Chen M, Aasi S, et al. Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol. 2000;20(6):416–423.
   PubMed Web of Science ®Google Scholar
• Sitaru C, Mihai S, Otto C, et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest. 2005;115(4):870–878.
   PubMed Web of Science ®Google Scholar
• Sitaru C, Chiriac MT, Mihai S, et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol. 2006;177(5):3461–3468.
   PubMed Web of Science ®Google Scholar
• Sitaru C, Kromminga A, Hashimoto T, et al. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol. 2002;161(1):301–311.
   PubMed Web of Science ®Google Scholar
• Borradori L, Caldwell JB, Briggaman RA, et al. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol. 1995;131(5):590–595.
   PubMedGoogle Scholar
• Chen M, Doostan A, Bandyopadhyay P, et al. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol. 2007;170(6):2009–2018.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Chang C, Saadat P, et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol. 2005;124(5):958–964.
   PubMed Web of Science ®Google Scholar
• Umemoto H, Akiyama M, Domon T, et al. Type VII collagen deficiency causes defective tooth enamel formation due to poor differentiation of ameloblasts. Am J Pathol. 2012;181(5):1659–1671
   PubMed Web of Science ®Google Scholar
• Iwata H, Bieber K, Tiburzy B, et al. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. J Immunol. 2013;191(6):2978–2988.
   PubMed Web of Science ®Google Scholar
• Hellberg L, Samavedam UK, Holdorf K, et al. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation. J Invest Dermatol. 2013;133(10):2390–2399.
   PubMed Web of Science ®Google Scholar
• Sadeghi H, Gupta Y, Moller S, et al. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita. J Pathol. 2015;237(1):111–122.
   PubMed Web of Science ®Google Scholar
• Tukaj S, Hellberg L, Ueck C, et al. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. Exp Dermatol. 2015;24(6):471–473.
   PubMed Web of Science ®Google Scholar
• Kasperkiewicz M, Muller R, Manz R, et al. Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. Blood. 2011;117(23):6135–6142.
   PubMed Web of Science ®Google Scholar
• Mihai S, Chiriac MT, Takahashi K, et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol. 2007;178(10):6514–6521.
   PubMed Web of Science ®Google Scholar
• Chiriac MT, Roesler J, Sindrilaru A, et al. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol. 2007;212(1):56–65.
   PubMed Web of Science ®Google Scholar
• Ellebrecht CT, Srinivas G, Bieber K, et al. Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita. J Autoimmun. 2016;68:14–22.
   PubMed Web of Science ®Google Scholar
• Hirose M, Vafia K, Kalies K, et al. Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun. 2012;39(4):304–314.
   PubMed Web of Science ®Google Scholar
• Karsten CM, Pandey MK, Figge J, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med. 2012;18(9):1401–1406.
   PubMed Web of Science ®Google Scholar
• Sadeghi H, Lockmann A, Hund AC, et al. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules. J Immunol. 2015;194(8):3656–3663.
   PubMed Web of Science ®Google Scholar
• Briggaman RA, Gammon WR, Woodley DT. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol. 1985;85(1 Suppl):79s–84s.
   PubMed Web of Science ®Google Scholar
• Joly P, Baricault S, Sparsa A, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132(8):1998–2004.
   PubMed Web of Science ®Google Scholar
• Langan SM, Smeeth L, Hubbard R, et al. Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based cohort study. Bmj. 2008;337:a180.
   PubMed Web of Science ®Google Scholar
• Marazza G, Pham HC, Scharer L, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161(4):861–868.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Borradori L, Joly P. Epidemiology of autoimmune bullous diseases. In: Murrell D, editors. Blistering diseases. 1st ed. Heidelberg: Springer; 2015. p. 251–264.
   Google Scholar
• Schmidt E, Della Torre R, Borradori L. Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin. 2011;29(3):427–438, viii–ix.
   Web of Science ®Google Scholar
• Gammon WR, Briggaman RA, Wheeler CE Jr Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol. 1982;7(3):382–387.
   PubMed Web of Science ®Google Scholar
• Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–379.
   PubMedGoogle Scholar
• Luke MC, Darling TN, Hsu R, et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol. 1999;135(8):954–959.
   PubMedGoogle Scholar
• Letko E, Bhol K, Anzaar F, et al. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. Arch Ophthalmol. 2006;124(11):1615–1618.
   PubMedGoogle Scholar
• Lang PG Jr, Tapert MJ. Severe ocular involvement in a patient with epidermolysis bullosa acquisita. J Am Acad Dermatol. 1987;16(2 Pt 2):439–443.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Briggaman RA, Gammon WT. Review and update of epidermolysis bullosa acquisita. Semin Dermatol. 1988;7(2):111–122.
   PubMedGoogle Scholar
• Alexandre M, Brette MD, Pascal F, et al. A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid. Medicine (Baltimore). 2006;85(4):239–252.
   PubMed Web of Science ®Google Scholar
• Schattenkirchner S, Lemann M, Prost C, et al. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn’s disease. Am J Gastroenterol. 1996;91(8):1657–1659.
   PubMed Web of Science ®Google Scholar
• Vodegel RM, De Jong MC, Pas HH, et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol. 2002;47(6):919–925.
   PubMed Web of Science ®Google Scholar
• Bauer JW, Schaeppi H, Metze D, et al. Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol. 1999;141(5):887–892.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Ishiko A, Shimizu H, et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol. 1996;134(2):336–339.
   PubMed Web of Science ®Google Scholar
• Ls Cm C, Woodley DT. Epidermolysis bullosa acquisita in the elderly. Clinical manifestationsdiagnosis and therapy. J Geriatr Dermatol. 1996;4:47–52.
   Google Scholar
• Brunsting LA, Perry HO. Benign pemphigold; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. AMA Arch Derm. 1957;75(4):489–501.
   PubMedGoogle Scholar
• Lee CW, Jun KM. Epidermolysis bullosa acquisita presenting with localized facial blisters. Clin Exp Dermatol. 1992;17(5):363–365.
   PubMed Web of Science ®Google Scholar
• Choi GS, Lee ES, Kim SC, et al. Epidermolysis bullosa acquisita localized to the face. J Dermatol. 1998;25(1):19–22.
   PubMedGoogle Scholar
• Joly P, Ruto F, Thomine E, et al. Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? J Am Acad Dermatol. 1993;28(1):89–92.
   PubMed Web of Science ®Google Scholar
• Abrams ML, Smidt A, Benjamin L, et al. Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant. Arch Dermatol. 2010;147(3):337–341.
   PubMedGoogle Scholar
• Yaoita H, Briggaman RA, Lawley TJ, et al. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol. 1981;76(4):288–292.
   PubMed Web of Science ®Google Scholar
• Chen M, Chan LS, Cai X, et al. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol. 1997;108(1):68–72.
   PubMed Web of Science ®Google Scholar
• Vodegel RM, Jonkman MF, Pas HH, et al. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151(1):112–118.
   PubMed Web of Science ®Google Scholar
• Woodley DT, Remington J, Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol. 2007;33(1–2):78–84.
   PubMed Web of Science ®Google Scholar
• Gibbs RB, Minus HR. Epidermolysis bullosa acquisita with electron microscopical studies. Arch Dermatol. 1975;111(2):215–220.
   PubMedGoogle Scholar
• Fine JD, Tyring S, Gammon WR. The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol. 1989;92(1):27–32.
   PubMed Web of Science ®Google Scholar
• Briggaman RA, Schechter NM, Fraki J, et al. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med. 1984;160(4):1027–1042.
   PubMed Web of Science ®Google Scholar
• Klein GF, Hintner H, Schuler G, et al. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. Br J Dermatol. 1983;109(5):499–508.
   PubMed Web of Science ®Google Scholar
• Briggaman RA, Wheeler CE Jr The epidermal-dermal junction. J Invest Dermatol. 1975;65(1):71–84.
   PubMed Web of Science ®Google Scholar
• Nieboer C, Boorsma DM, Woerdeman MJ, et al. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol. 1980;102(4):383–392.
   PubMed Web of Science ®Google Scholar
• Prost C, Labeille B, Chaussade V, et al. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol. 1987;89(6):567–573.
   PubMed Web of Science ®Google Scholar
• Prost C, Dubertret L, Fosse M, et al. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol. 1984;110(1):1–7.
   PubMed Web of Science ®Google Scholar
• Shimizu H, McDonald JN, Gunner DB, et al. Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane. Br J Dermatol. 1990;122(5):577–585.
   PubMed Web of Science ®Google Scholar
• Karpati S, Stolz W, Meurer M, et al. In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol. 1992;26(5 Pt 1):726–730.
   PubMed Web of Science ®Google Scholar
• Vaughn Jones SA, Palmer I, Bhogal BS, et al. The use of Michel’s transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol. 1995;22(4):365–370.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Goebeler M, Hertl M, et al. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges. 2015;13(7):713–727.
   PubMed Web of Science ®Google Scholar
• Terra JB, Meijer JM, Jonkman MF, et al. The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Br J Dermatol. 2013;169(1):100–105.
   PubMed Web of Science ®Google Scholar
• Terra JB, Pas HH, Hertl M, et al. Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients. Br J Dermatol. 2011;165(4):815–822.
   PubMed Web of Science ®Google Scholar
• Woodley D, Sauder D, Talley MJ, et al. Localization of basement membrane components after dermal-epidermal junction separation. J Invest Dermatol. 1983;81(2):149–153.
   PubMed Web of Science ®Google Scholar
• Goletz S, Hashimoto T, Zillikens D, et al. Anti-p200 pemphigoid. J Am Acad Dermatol. 2014;71(1):185–191.
   PubMed Web of Science ®Google Scholar
• Bruins S, De Jong MC, Heeres K, et al. Fluorescence overlay antigen mapping of the epidermal basement membrane zone: III. Topographic staining and effective resolution. J Histochem Cytochem. 1995;43(7):649–656.
   PubMed Web of Science ®Google Scholar
• De Jong MC, Bruins S, Heeres K, et al. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol. 1996;132(2):151–157.
   PubMedGoogle Scholar
• Wozniak K, Kazama T, Kowalewski C. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol. 2003;139(8):1007–1011.
   PubMedGoogle Scholar
• Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010;10(2):84–89.
   PubMed Web of Science ®Google Scholar
• Blocker IM, Dahnrich C, Probst C, et al. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol. 2012;166(5):964–970.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Dahnrich C, Rosemann A, et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol. 2010;19(5):458–463.
   PubMed Web of Science ®Google Scholar
• Sitaru C, Dahnrich C, Probst C, et al. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol. 2007;16(9):770–777.
   PubMed Web of Science ®Google Scholar
• Van Beek N, Knuth-Rehr D, Altmeyer P, et al. Diagnostics of autoimmune bullous diseases in German dermatology departments. J Dtsch Dermatol Ges. 2012;10(7):492–499.
   PubMed Web of Science ®Google Scholar
• Van Beek N, Rentzsch K, Probst C, et al. Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis. 2012;7(1):49.
   PubMed Web of Science ®Google Scholar
• Seta V, Aucouturier F, Bonnefoy J, et al. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). J Am Acad Dermatol. 2016;74(6):1166–1172.
   PubMed Web of Science ®Google Scholar
• Gammon WR, Briggaman RA, Inman AO III, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984;82(2):139–144.
   PubMed Web of Science ®Google Scholar
• Domloge-Hultsch N, Anhalt GJ, Gammon WR, et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol. 1994;130(12):1521–1529.
   PubMedGoogle Scholar
• Zillikens D, Kawahara Y, Ishiko A, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol. 1996;106(6):1333–1338.
   PubMed Web of Science ®Google Scholar
• Calabresi V, Sinistro A, Cozzani E, et al. Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients. J Eur Acad Dermatol Venereol. 2014;28(4):483–490.
   PubMed Web of Science ®Google Scholar
• Delgado L, Aoki V, Santi C, et al. Clinical and immunopathological evaluation of epidermolysis bullosa acquisita. Clin Exp Dermatol. 2011;36(1):12–18.
   PubMed Web of Science ®Google Scholar
• Ghohestani RF, Nicolas JF, Rousselle P, et al. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol. 1997;133(9):1102–1107.
   PubMedGoogle Scholar
• Jonkman MF, Schuur J, Dijk F, et al. Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol. 2000;136(2):227–231.
   PubMedGoogle Scholar
• Vodegel RM, Kiss M, Cjm De Jong M, et al. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol. 1998;8(2):83–85.
   PubMed Web of Science ®Google Scholar
• Chen M, Costa FK, Lindvay CR, et al. The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J Biol Chem. 2002;277(3):2118–2124.
   PubMed Web of Science ®Google Scholar
• Grootenboer-Mignot S, Descamps V, Picard-Dahan C, et al. Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses. Br J Dermatol. 2010;162(4):743–750.
   PubMed Web of Science ®Google Scholar
• Oyama N, Bhogal BS, Carrington P, et al. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br J Dermatol. 2003;148(5):939–944.
   PubMed Web of Science ®Google Scholar
• Batteux F, Franck N, Jaffray P, et al. An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. J Clin Immunol. 1997;17(3):228–233.
   PubMed Web of Science ®Google Scholar
• Terra JB, Jonkman MF, Diercks GF, et al. Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. Br J Dermatol. 2013;169(1):164–167.
   PubMed Web of Science ®Google Scholar
• Horvath ON, Varga R, Kaneda M, et al. Diagnostic performance of the “MESACUP anti-Skin profile TEST”. Eur J Dermatol. 2016;26(1):56–63.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YH, Kim S, et al. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol. 2012;27(2):e224–230.
   PubMed Web of Science ®Google Scholar
• Tampoia M, Zucano A, Villalta D, et al. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases. Dermatology. 2012;225(1):37–44.
   PubMed Web of Science ®Google Scholar
• Russo I, Saponeri A, Peserico A, et al. The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris. Acta Histochem. 2014;116(5):713–716.
   PubMed Web of Science ®Google Scholar
• Zarian H, Saponeri A, Michelotto A, et al. Biochip technology for the serological diagnosis of bullous pemphigoid. ISRN Dermatol. 2012;2012:237802.
   PubMedGoogle Scholar
• Gornowicz-Porowska J, Dmochowski M, Pietkiewicz P, et al. Mucosal-dominant pemphigus vulgaris in a captopril-taking woman with angioedema. An Bras Dermatol. 2015;90(5):748–751.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Cozzani E, Biasin M, et al. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita. Arch Dermatol Res. 2016;308(4):273–276.
   PubMed Web of Science ®Google Scholar